{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T15:03:21Z","timestamp":1783609401751,"version":"3.55.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2020D01A119"],"award-info":[{"award-number":["2020D01A119"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82060038"],"award-info":[{"award-number":["82060038"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100015310","name":"Natural Science Foundation of Xinjiang","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100015310","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.humimm.2023.07.007","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T03:57:01Z","timestamp":1689911821000},"page":"551-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Lower PTEN may be associated with CD8+ T cell exhaustion in diffuse large B-cell lymphoma"],"prefix":"10.1016","volume":"84","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9000-0148","authenticated-orcid":false,"given":"Shutao","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiajia","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junna","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuelian","family":"Pang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mingfu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiping","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2023.07.007_b0005","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2023.07.007_b0010","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41577-019-0221-9","article-title":"Defining 'T cell exhaustion'","volume":"19","author":"Blank","year":"2019","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.07.007_b0015","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1158\/2326-6066.CIR-18-0351","article-title":"TIGIT and PD-1 mark intratumoral T cells with reduced effector function in B-cell non-Hodgkin lymphoma","volume":"7","author":"Josefsson","year":"2019","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.humimm.2023.07.007_b0020","doi-asserted-by":"crossref","first-page":"6968595","DOI":"10.1155\/2020\/6968595","article-title":"Genetic mutations of Tim-3 ligand and exhausted Tim-3(+) CD8(+) T cells and survival in diffuse large B cell lymphoma","volume":"2020","author":"Zhang","year":"2020","journal-title":"J. Immunol. Res."},{"key":"10.1016\/j.humimm.2023.07.007_b0025","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1182\/bloodadvances.2020003080","article-title":"Functional characterization of PD1+TIM3+ tumor-infiltrating T cells in DLBCL and effects of PD1 or TIM3 blockade","volume":"5","author":"Roussel","year":"2021","journal-title":"Blood Adv."},{"key":"10.1016\/j.humimm.2023.07.007_b0030","doi-asserted-by":"crossref","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses","volume":"45","author":"Tang","year":"2017","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2023.07.007_b0035","doi-asserted-by":"crossref","first-page":"W509","DOI":"10.1093\/nar\/gkaa407","article-title":"TIMER2.0 for analysis of tumor-infiltrating immune cells","volume":"48","author":"Li","year":"2020","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.humimm.2023.07.007_b0040","first-page":"13","article-title":"The PD-1\/PD-L1 checkpoint in normal germinal centers and diffuse large B-cell lymphomas","author":"Garcia-Lacarte","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2023.07.007_b0045","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2021.107662","article-title":"High levels of Tim-3(+)Foxp3(+)Treg cells in the tumor microenvironment is a prognostic indicator of poor survival of diffuse large B cell lymphoma patients","volume":"96","author":"Zhong","year":"2021","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.humimm.2023.07.007_b0050","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/s41590-020-00850-9","article-title":"IL-2 regulates tumor-reactive CD8(+) T cell exhaustion by activating the aryl hydrocarbon receptor","volume":"22","author":"Liu","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2023.07.007_b0055","doi-asserted-by":"crossref","first-page":"2003533","DOI":"10.1080\/2162402X.2021.2003533","article-title":"Tumor cell-derived IL-10 promotes cell-autonomous growth and immune escape in diffuse large B-cell lymphoma","volume":"10","author":"Stirm","year":"2021","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.humimm.2023.07.007_b0060","doi-asserted-by":"crossref","first-page":"2637581","DOI":"10.1155\/2022\/2637581","article-title":"Expression and prognostic value of PIK3CA, VEGF, IL-8, IL-10, and RIP2 in diffuse large B-cell lymphoma","volume":"2022","author":"Shen","year":"2022","journal-title":"Int. J. Clin. Pract."},{"key":"10.1016\/j.humimm.2023.07.007_b0065","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2020.155048","article-title":"Pre-treatment serum IL-10 predicts the risk of secondary central nervous system involvement in patients with diffuse large B-cell lymphoma","volume":"129","author":"Yi","year":"2020","journal-title":"Cytokine"},{"key":"10.1016\/j.humimm.2023.07.007_b0070","doi-asserted-by":"crossref","unstructured":"S.M. Al-Khatib, N. Abdo, L.N. Al-Eitan, A.H. Al-Mistarehi, D.J. Zahran, T.Z. Kewan, The impact of IL-6 and IL-10 gene polymorphisms in diffuse large B-cell lymphoma risk and overall survival in an Arab population: a case-control study, Cancers (Basel) 12 (2020).","DOI":"10.3390\/cancers12020382"},{"key":"10.1016\/j.humimm.2023.07.007_b0075","doi-asserted-by":"crossref","first-page":"66237","DOI":"10.18632\/oncotarget.19889","article-title":"PIK3CA amplification and PTEN loss in diffused large B-cell lymphoma","volume":"8","author":"Cui","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2023.07.007_b0080","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1016\/j.neo.2018.03.002","article-title":"Clinical significance of PTEN deletion, mutation, and loss of PTEN expression in De Novo diffuse large B-cell lymphoma","volume":"20","author":"Wang","year":"2018","journal-title":"Neoplasia"},{"key":"10.1016\/j.humimm.2023.07.007_b0085","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1111\/his.13106","volume":"70","author":"Carreras","year":"2017","journal-title":"Histopathology"},{"key":"10.1016\/j.humimm.2023.07.007_b0090","first-page":"14875","article-title":"Evaluation of AKT phosphorylation and PTEN loss and their correlation with the resistance of rituximab in DLBCL","volume":"8","author":"Ma","year":"2015","journal-title":"Int. J. Clin. Exp. Path."},{"key":"10.1016\/j.humimm.2023.07.007_b0095","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.2174\/1871520619666190925143216","article-title":"Signal Pathways and Therapeutic Prospects of Diffuse Large B Cell Lymphoma","volume":"19","author":"Sun","year":"2019","journal-title":"Anticancer Agents Med Chem."},{"key":"10.1016\/j.humimm.2023.07.007_b0100","first-page":"14","article-title":"Artificial Intelligence Predicted Overall Survival and Classified Mature B-Cell Neoplasms Based on Immuno-Oncology and Immune Checkpoint Panels","author":"Carreras","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2023.07.007_b0105","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/nature05115","article-title":"PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression","volume":"443","author":"Day","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2023.07.007_b0110","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.tim.2007.02.006","article-title":"IL-10, T cell exhaustion and viral persistence","volume":"15","author":"Blackburn","year":"2007","journal-title":"Trends Microbiol."},{"key":"10.1016\/j.humimm.2023.07.007_b0115","doi-asserted-by":"crossref","first-page":"8623","DOI":"10.1073\/pnas.0809818106","article-title":"High antigen levels are the cause of T cell exhaustion during chronic viral infection","volume":"106","author":"Mueller","year":"2009","journal-title":"PNAS"},{"key":"10.1016\/j.humimm.2023.07.007_b0120","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1084\/jem.20100643","article-title":"Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity","volume":"207","author":"Sakuishi","year":"2010","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.humimm.2023.07.007_b0125","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.18632\/oncotarget.26771","article-title":"The immune checkpoint molecules PD-1, PD-L1, TIM-3 and LAG-3 in diffuse large B-cell lymphoma","volume":"10","author":"Chen","year":"2019","journal-title":"Oncotarget"},{"key":"10.1016\/j.humimm.2023.07.007_b0130","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/bjh.17083","article-title":"Exhaustion of tumour-infiltrating T-cell receptor repertoire diversity is an age-dependent indicator of immunological fitness independently predictive of clinical outcome in Burkitt lymphoma","volume":"193","author":"Rieken","year":"2021","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.humimm.2023.07.007_b0135","first-page":"12","article-title":"Mechanisms of T-Cell Exhaustion in Pancreatic Cancer","author":"Saka","year":"2020","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2023.07.007_b0140","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1007\/s00262-020-02593-w","article-title":"Expression of immune checkpoints and T cell exhaustion markers in early and advanced stages of colorectal cancer","volume":"69","author":"Saleh","year":"2020","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.humimm.2023.07.007_b0145","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1038\/nri3862","article-title":"Molecular and cellular insights into T cell exhaustion","volume":"15","author":"Wherry","year":"2015","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.humimm.2023.07.007_b0150","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.715234","article-title":"CD8(+) T Cell Exhaustion in Cancer","volume":"12","author":"Dolina","year":"2021","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2023.07.007_b0155","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00281-019-00744-5","article-title":"CD8(+) T cell exhaustion","volume":"41","author":"Kurachi","year":"2019","journal-title":"Semin. Immunopathol."},{"key":"10.1016\/j.humimm.2023.07.007_b0160","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13174279","article-title":"Clinical and Product Features Associated with Outcome of DLBCL Patients to CD19-Targeted CAR T-Cell Therapy","volume":"13","author":"Lamure","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.humimm.2023.07.007_b0165","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1038\/s41423-021-00712-w","article-title":"The two faces of IL-2: a key driver of CD8(+) T-cell exhaustion","volume":"18","author":"Kwon","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.humimm.2023.07.007_b0170","first-page":"2846","article-title":"Expression of PD-1, TIM-3, LAG-3 and BTLA in diffuse large B-cell lymphoma and its effect on prognosis","volume":"100","author":"Liu","year":"2020","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/j.humimm.2023.07.007_b0175","first-page":"569","article-title":"S SP, Syrigos N, Marinos L, Pouliou E, Papanikolaou A: Clinical significance of PD-1 and PD-L1 molecules in patients with diffuse large B-cell lymphoma, not otherwise specified: Correlation with clinical and pathological findings","volume":"26","author":"Karakatsanis","year":"2021","journal-title":"J. B.U.ON."},{"key":"10.1016\/j.humimm.2023.07.007_b0180","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1097\/PAS.0000000000000094","article-title":"TNF-alpha expression in tumor cells as a novel prognostic marker for diffuse large B-cell lymphoma, not otherwise specified","volume":"38","author":"Nakayama","year":"2014","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.humimm.2023.07.007_b0185","doi-asserted-by":"crossref","first-page":"e6398","DOI":"10.1097\/MD.0000000000006398","article-title":"The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma","volume":"96","author":"Fang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.humimm.2023.07.007_b0190","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1186\/s40880-017-0262-z","article-title":"Expression and clinical value of programmed cell death-ligand 1 (PD-L1) in diffuse large B cell lymphoma: a retrospective study","volume":"36","author":"Hu","year":"2017","journal-title":"Chin. J. Cancer"},{"key":"10.1016\/j.humimm.2023.07.007_b0195","doi-asserted-by":"crossref","unstructured":"H. Vajavaara, J.B. Mortensen, S.K. Leivonen, I.M. Hansen, M. Ludvigsen, H. Holte, et al., Soluble PD-1 but Not PD-L1 Levels Predict Poor Outcome in Patients with High-Risk Diffuse Large B-Cell Lymphoma, Cancers (Basel) 13 (2021).","DOI":"10.3390\/cancers13030398"},{"key":"10.1016\/j.humimm.2023.07.007_b0200","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.prp.2018.03.001","article-title":"Expression of programmed cell death 1\/programmed cell death ligand 1 in the tumor microenvironments of primary gastrointestinal diffuse large B cell lymphomas","volume":"214","author":"Liu","year":"2018","journal-title":"Pathol. Res. Pract."},{"key":"10.1016\/j.humimm.2023.07.007_b0205","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s12967-020-02219-w","article-title":"Is there a causal link between PTEN deficient tumors and immunosuppressive tumor microenvironment?","volume":"18","author":"Cetintas","year":"2020","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.humimm.2023.07.007_b0210","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1186\/s12885-021-08114-x","article-title":"PTEN loss correlates with T cell exclusion across human cancers","volume":"21","author":"Lin","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.humimm.2023.07.007_b0215","doi-asserted-by":"crossref","first-page":"12420","DOI":"10.1073\/pnas.1305656110","article-title":"PTEN loss defines a PI3K\/AKT pathway-dependent germinal center subtype of diffuse large B-cell lymphoma","volume":"110","author":"Pfeifer","year":"2013","journal-title":"PNAS"},{"key":"10.1016\/j.humimm.2023.07.007_b0220","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1038\/nature14404","article-title":"Melanoma-intrinsic beta-catenin signalling prevents anti-tumour immunity","volume":"523","author":"Spranger","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.humimm.2023.07.007_b0225","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/s43018-019-0003-0","article-title":"PAK4 inhibition improves PD-1 blockade immunotherapy","volume":"1","author":"Abril-Rodriguez","year":"2020","journal-title":"Nat Cancer"},{"key":"10.1016\/j.humimm.2023.07.007_b0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s13045-017-0471-6","article-title":"Wnt\/beta-catenin pathway: modulating anticancer immune response","volume":"10","author":"Pai","year":"2017","journal-title":"J. Hematol. Oncol."},{"key":"10.1016\/j.humimm.2023.07.007_b0235","doi-asserted-by":"crossref","first-page":"3074","DOI":"10.1158\/1078-0432.CCR-18-1942","article-title":"WNT\/beta-catenin Pathway Activation Correlates with Immune Exclusion across Human Cancers","volume":"25","author":"Luke","year":"2019","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.humimm.2023.07.007_b0240","doi-asserted-by":"crossref","DOI":"10.1126\/scisignal.2005654","article-title":"FOXP1 potentiates Wnt\/beta-catenin signaling in diffuse large B cell lymphoma","volume":"8","author":"Walker","year":"2015","journal-title":"Sci. Signal."},{"key":"10.1016\/j.humimm.2023.07.007_b0245","doi-asserted-by":"crossref","first-page":"7001","DOI":"10.7150\/jca.47816","article-title":"Plasma soluble PD-L1 and STAT3 predict the prognosis in diffuse large B cell lymphoma patients","volume":"11","author":"Fei","year":"2020","journal-title":"J. Cancer"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923001167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885923001167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T11:58:23Z","timestamp":1759319903000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885923001167"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":49,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S0198885923001167"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2023.07.007","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lower PTEN may be associated with CD8+ T cell exhaustion in diffuse large B-cell lymphoma","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2023.07.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}